Enteral Syringes Market Expected To Grow At A CAGR Of 5.3% During The Forecast Period

(prsubmissions) October 10, 2019 – The latest market report published by Credence Research, Inc. “ Enteral syringes Market : Growth, Future Prospects, and Competitive Analysis, 2019 – 2027” the enteral syringes market was valued at US$ 528.6 Mn in 2018, expected to grow at a CAGR of 5.3% during the forecast period from 2019 to 2027.

Browse Full Report Originally Published by Credence Research @ https://www.credenceresearch.com/report/enteral-syringes-market

Market Insights

The global market for enteral syringes has been steadily increasing from 2019 to 2027, approved to increase hospital admissions for cancer, lifestyle disorders, obesity and others. Increased approvals by the U.S. FDA (510k clearance) for new enteral syringes with improved tip technology would accelerate market growth on a global scale. Increasing alliances, innovation development and the release of new products would contribute a significant revenue share internationally. In February 2017, Baxter International Inc. expanded its food treatment range by adding a new ENFit enteral syringe and attachment line for patients needing tube feeding. Enteral syringes are primarily used for oral and enteral administration of medications and food.

Increasing NICU patients along with hospital admissions of pediatric and adult patients to hospitals will further fuel revenue growth for the enteral syringe industry. Improved regulatory policies for the manufacture of syringes will also improve market growth.  For example. ENFit is designed to improve overall patient safety. In addition, keeping with the latest ISO 80369-3 standard. This helps neonate, pediatric and adult patients needing nutritional therapy.

You can get the sample copy of this research by Credence Research here @ https://www.credenceresearch.com/sample-request/59931

Top companies focused mainly on new inventions and FDA 510k clearance on a global scale, particularly in the U.S. market. Increasing numbers of newborns with hospital admissions, patients with late-stage disease, gastrointestinal disease, neurology and hyper metabolism will increase demand for enteral syringes.

Each year, more than 100,000 newborn babies are cared for in neonatal units in the United Kingdom, mainly due to premature birth or disease. For example, in 2016, 100,762 newborn babies received neonatal care in Scotland, England and Wales (born 25-26 weeks earlier). The U.S. market contributed the maximum revenue share due to the increasing prevalence of chronic diseases, urinary disorders, end-stage kidney disease, obesity, hypertension, a large pool of geriatrics, and the home of main manufacturers in the North American area.

Developed home care settings for a smooth transition, growing preference for single-use goods, increasing awareness of advanced techniques and nutritional therapy practices in developing nations globally are key factors driving market growth.

Key Market Movements:

• Globally, the enteral syringes is growing at a CAGR of 5.3% for the period from 2019 to 2027
• Increased general health awareness along with huge hospital admissions will drive the market growth the Asia Pacific region owing to developments in healthcare infrastructure, rise in medical expenditure, and medical tourism
• Increased funding by government and private organizations for better treatment options
• New product launch along with U.S FDA approval and technology expansion will drive the market growth

You can get the sample copy of this research by Credence Research here @ https://www.credenceresearch.com/sample-request/59931

• Major players in this vertical are Cardinal Health Inc., Merit Medical Systems Inc., B. Braun Melsungen AG, Baxter International, Inc., Terumo Corporation, Vygon S.A., Koninklijke Philips N.V., Retractable Technologies Inc., Medline Industries Inc., Gerresheimer AG, Abbott Laboratories Inc., Kentec Medical, Inc., Miktell Ltd., Thermo Fischer, Inc. and others